• Arimoclomol in Sporadic Inclusion Body Myositis
• Phase II/III Randomized, Placebo-controlled Trial of Arimoclomol in SOD1 Positive Familial Amyotrophic Lateral Sclerosis
• Arimoclomol in Amyotropic Lateral Sclerosis - Open Label Extension Trial
• Study of Arimoclomol in Patients Diagnosed With Gaucher Disease Type 1 or 3
• A Prospective Non-therapeutic Study in Patients Diagnosed With Niemann-Pick Disease Type C
• Arimoclomol Prospective Study in Participants Diagnosed With Niemann-Pick Disease Type C
• Early Access Program With Arimoclomol in US Patients With NPC
• A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS
• Study of Arimoclomol in Inclusion Body Myositis (IBM)
• Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial
• Arimoclomol in Amyotropic Lateral Sclerosis
• A Multicenter, Dose Ranging Safety and Pharmacokinetics Study of Arimoclomol in ALS